TyrNovo Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer (NCT04474470) | TyrNovo Ltd. | 2020-09-03 |
Track TyrNovo Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.